[Scleroderma (progressive systemic sclerosis)].
Explore the source record for details and available documents.
Adult↗
Biomedical subjects
M Chevallard
Publications and source records attributed to M Chevallard.
Effectiveness and tolerability of ketoprofen lysine, once a day, in patients with rheumatic disorders.
Ketoprofen lysine (KL) at a dose of 160 mg b.i.d. has been shown to have favourable anti-inflammatory and analgesic properties in a large number of patients. In the present paper investigators describe their experience with a new therapeutic schedule of KL, 320 mg given once a day to patients with various rheumatic disorders. With this new schedule there was satisfactory clinical improvement of most of the clinical parameters and good tolerability, with a low incidence of gastric troubles. The favourable clinical effects and the patients' good compliance with once-a-day KL make it a useful drug for successful treatment of rheumatic disorders.
Drug Administration Schedule↗
[Pilot study on the use of captopril in treatment of refractory rheumatoid arthritis].
Explore the source record for details and available documents.
Adult↗